(株)レナサイエンスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4889/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2024/04/12 | 日証協 | 709,000株 | -10.4% | 0株 | -100% | 989,331株 | +0.14% | 47,415株 | -71.19% |
| 2024/04/05 | 日証協 | 791,300株 | +0.92% | 16,600株 | +225.49% | 987,916株 | -0.47% | 164,600株 | +50.32% |
| 2024/03/29 | 日証協 | 784,100株 | -0.46% | 5,100株 | -41.38% | 992,614株 | -5.46% | 109,502株 | +201.66% |
| 2024/03/22 | 日証協 | 787,700株 | +1.04% | 8,700株 | -85.3% | 1,049,916株 | +3.14% | 36,300株 | +12.73% |
| 2024/03/15 | 日証協 | 779,600株 | -1% | 59,200株 | +9999.99% | 1,017,916株 | +0.23% | 32,200株 | -64.18% |
| 2024/03/08 | 日証協 | 787,500株 | -0.32% | 100株 | -99.7% | 1,015,616株 | -0.31% | 89,900株 | -8.27% |
| 2024/03/01 | 日証協 | 790,000株 | +3.39% | 32,800株 | 0% | 1,018,816株 | +0.19% | 98,000株 | +798.84% |
| 2024/02/22 | 日証協 | 764,100株 | -2.38% | 0株 | 0% | 1,016,919株 | -0.89% | 10,903株 | -85.71% |
| 2024/02/16 | 日証協 | 782,700株 | -3.22% | 0株 | 0% | 1,026,046株 | -1.81% | 76,313株 | +1396.33% |
| 2024/02/09 | 日証協 | 808,700株 | -2.31% | 0株 | 0% | 1,044,946株 | -0.56% | 5,100株 | -77.03% |
| 2024/02/02 | 日証協 | 827,800株 | -1.13% | 0株 | -100% | 1,050,846株 | +0.42% | 22,200株 | +208.33% |
| 2024/01/26 | 日証協 | 837,300株 | -2.42% | 5,100株 | +82.14% | 1,046,446株 | -1.69% | 7,200株 | -6.49% |
| 2024/01/19 | 日証協 | 858,100株 | -1.74% | 2,800株 | +75% | 1,064,456株 | -1.32% | 7,700株 | +14.75% |
| 2024/01/12 | 日証協 | 873,300株 | -1.49% | 1,600株 | -61.9% | 1,078,646株 | -5.04% | 6,710株 | +34.2% |
| 2024/01/05 | 日証協 | 886,500株 | -4.12% | 4,200株 | +5% | 1,135,846株 | +4.17% | 5,000株 | -96.45% |
| 2023/12/29 | 日証協 | 924,600株 | -6.14% | 4,000株 | -49.37% | 1,090,346株 | -5.78% | 140,900株 | +653.48% |
| 2023/12/22 | 日証協 | 985,100株 | -4.26% | 7,900株 | -93.43% | 1,157,246株 | -1.81% | 18,700株 | -71.54% |
| 2023/12/15 | 日証協 | 1,028,900株 | +4.23% | 120,200株 | +901.67% | 1,178,636株 | +2.25% | 65,710株 | +117.56% |
| 2023/12/08 | 日証協 | 987,100株 | -1.22% | 12,000株 | +41.18% | 1,152,752株 | -0.25% | 30,203株 | +125.29% |
※株式分割は考慮していませんのでご注意ください。
Page Top